TFX
$235.38
Teleflex
($1.96)
(.83%)
TFX
Earnings Whisper ®
N/A
3rd Quarter September 2024
Consensus:  $3.38
Revenue:  $769.28 Mil
Thursday
Oct 31
6:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when TFX reports earnings?
Beat
Meet
Miss

Where is TFX's stock price going from here?
Up
Flat
Down
Stock chart of TFX
Analysts
Summary of analysts' recommendations for TFX
Score
Grade
Pivots
Resistance
$243.99
$242.13
$238.75

$236.89

Support
$233.52
$231.66
$228.28
Tweet
Growth
Description
Teleflex is a global provider of medical technology products. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company markets and sells its products to hospitals and healthcare providers worldwide through a combination of direct sales force and distributors. Teleflex has manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States.
Peers
Boston ScientificStrykerAbbottBecton, DickinsonWaters3MResMedBaxter InternationalIntegra LifeSciences HoldingsMerit Medical Systems